These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30322602)

  • 1. Economic and Societal Aspects of Stroke Management.
    Mukundan G; Seidenwurm DJ
    Neuroimaging Clin N Am; 2018 Nov; 28(4):683-689. PubMed ID: 30322602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of stroke: a systematic review on post-stroke care.
    Rajsic S; Gothe H; Borba HH; Sroczynski G; Vujicic J; Toell T; Siebert U
    Eur J Health Econ; 2019 Feb; 20(1):107-134. PubMed ID: 29909569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International comparison of stroke cost studies.
    Evers SM; Struijs JN; Ament AJ; van Genugten ML; Jager JH; van den Bos GA
    Stroke; 2004 May; 35(5):1209-15. PubMed ID: 15073405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of treating stroke in an Irish teaching hospital.
    McGowan B; Heerey A; Tilson L; Ryan M; Barry M
    Ir Med J; 2003 Sep; 96(8):234-6. PubMed ID: 14653374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of pediatric stroke care in the United States: a systematic and contemporary review.
    Ellis C; McGrattan K; Mauldin P; Ovbiagele B
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):643-50. PubMed ID: 24970735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of stroke and transient ischaemic attack in Ireland: a prevalence-based estimate.
    Smith S; Horgan F; Sexton E; Cowman S; Hickey A; Kelly P; McGee H; Murphy S; O'Neill D; Royston M; Shelley E; Wiley M
    Age Ageing; 2012 May; 41(3):332-8. PubMed ID: 22134905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Socio-economic aspects of stroke management].
    Spieler JF; Amarenco P
    Rev Neurol (Paris); 2004 Nov; 160(11):1023-8. PubMed ID: 15602344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical and cost burden of atherosclerosis among patients treated in routine clinical practice.
    Ohsfeldt RL; Gandhi SK; Fox KM; Bullano MF; Davidson M
    J Med Econ; 2010; 13(3):500-7. PubMed ID: 20673198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of transferring first-stroke survivors to rehabilitation wards: A 10-year longitudinal, population-based study.
    Chen CM; Yang YH; Lee M; Chen KH; Huang SS
    Top Stroke Rehabil; 2020 Jan; 27(1):8-14. PubMed ID: 31535585
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct Cost Related to Stroke: A Longitudinal Analysis of Survivors After Discharge From a Rehabilitation Hospital.
    Pucciarelli G; Rebora P; Arisido MW; Ausili D; Simeone S; Vellone E; Alvaro R
    J Cardiovasc Nurs; 2020; 35(1):86-94. PubMed ID: 31804249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of chronic cardiovascular disease for major insurers.
    Trogdon JG; Finkelstein EA; Nwaise IA; Tangka FK; Orenstein D
    Health Promot Pract; 2007 Jul; 8(3):234-42. PubMed ID: 17606951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of the occupation-based approach for subacute stroke patients: result of a randomized controlled trial.
    Nagayama H; Tomori K; Ohno K; Takahashi K; Nagatani R; Izumi R; Moriwaki K; Yamauchi K
    Top Stroke Rehabil; 2017 Jul; 24(5):337-344. PubMed ID: 28198661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
    Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct medical cost of stroke in Singapore.
    Ng CS; Toh MP; Ng J; Ko Y
    Int J Stroke; 2015 Oct; 10 Suppl A100():75-82. PubMed ID: 26179153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.
    Small C; Kramer HJ; Griffin KA; Vellanki K; Leehey DJ; Bansal VK; Markossian TW
    BMC Nephrol; 2017 Jan; 18(1):3. PubMed ID: 28056852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-occurring Chronic Conditions and Economic Burden among Stroke Survivors in the United States: A Propensity Score-Matched Analysis.
    Chinthammit C; Coull BM; Nimworapan M; Bhattacharjee S
    J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):393-402. PubMed ID: 27793537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute 'strokenomics': efficacy and economic analyses of alteplase for acute ischemic stroke.
    Quinn TJ; Dawson J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):513-22. PubMed ID: 19941428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of pediatric stroke care and rehabilitation.
    Lo W; Zamel K; Ponnappa K; Allen A; Chisolm D; Tang M; Kerlin B; Yeates KO
    Stroke; 2008 Jan; 39(1):161-5. PubMed ID: 18032740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satisfaction of Nigerian stroke survivors with outpatient physiotherapy care.
    Olaleye OA; Hamzat TK; Akinrinsade MA
    Physiother Theory Pract; 2017 Jan; 33(1):41-51. PubMed ID: 27892812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can be achieved by redesigning stroke care for a value-based world?
    Tai W; Kalanithi L; Milstein A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):585-7. PubMed ID: 25095813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.